BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 12753658)

  • 1. TNF-alpha polymorphisms and type 2 diabetes mellitus in Taiwanese patients.
    Shiau MY; Wu CY; Huang CN; Hu SW; Lin SJ; Chang YH
    Tissue Antigens; 2003 May; 61(5):393-7. PubMed ID: 12753658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor necrosis factor alpha gene G-308A polymorphism, insulin resistance, and fasting plasma glucose in young, older, and diabetic Japanese men.
    Ishii T; Hirose H; Saito I; Nishikai K; Maruyama H; Saruta T
    Metabolism; 2000 Dec; 49(12):1616-8. PubMed ID: 11145126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between tumour necrosis factor-alpha G-308A polymorphism and risk of nephropathy in obese Chinese type 2 diabetic patients.
    Wang Y; Ng MC; So WY; Ma R; Ko GT; Tong PC; Chan JC
    Nephrol Dial Transplant; 2005 Dec; 20(12):2733-8. PubMed ID: 16141456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoter polymorphisms of the TNF-alpha (G-308A) and IL-6 (C-174G) genes predict the conversion from impaired glucose tolerance to type 2 diabetes: the Finnish Diabetes Prevention Study.
    Kubaszek A; Pihlajamäki J; Komarovski V; Lindi V; Lindström J; Eriksson J; Valle TT; Hämäläinen H; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Tuomilehto J; Uusitupa M; Laakso M;
    Diabetes; 2003 Jul; 52(7):1872-6. PubMed ID: 12829659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of genetic polymorphisms of leptin and TNF-alpha on rosiglitazone response in Chinese patients with type 2 diabetes.
    Liu HL; Lin YG; Wu J; Sun H; Gong ZC; Hu PC; Yin JY; Zhang W; Wang D; Zhou HH; Liu ZQ
    Eur J Clin Pharmacol; 2008 Jul; 64(7):663-71. PubMed ID: 18438653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour necrosis factor-alpha gene promoter polymorphism and decreased insulin resistance.
    Day CP; Grove J; Daly AK; Stewart MW; Avery PJ; Walker M
    Diabetologia; 1998 Apr; 41(4):430-4. PubMed ID: 9562347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of TNF-alpha gene promoter C-857T polymorphism with higher serum LDL cholesterol levels and carotid plaque formation in Japanese patients with type 2 diabetes.
    Yamashina M; Kaneko Y; Maesawa C; Kajiwara T; Ishii M; Fujiwara F; Taneichi H; Takebe N; Ishida W; Takahashi K; Masuda T; Satoh J
    Tohoku J Exp Med; 2007 Mar; 211(3):251-8. PubMed ID: 17347550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of ADIPOQ C-11377G (rs266729), TNF-α αG-308A(rs1800629) and TNF-α αG-238A(rs361525) Single Nucleotide Polymorphisms with Type 2 Diabetes Mellitus in Pakistani Population.
    Nadeem A; Mumtaz S; Naveed AK; Mansoor Q; Aslam M; Ismail M
    J Coll Physicians Surg Pak; 2017 Oct; 27(10):625-630. PubMed ID: 29056124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between TNF-α promoter G-308A and G-238A polymorphisms and obesity.
    Hedayati M; Sharifi K; Rostami F; Daneshpour MS; Zarif Yeganeh M; Azizi F
    Mol Biol Rep; 2012 Feb; 39(2):825-9. PubMed ID: 21559831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor alpha -238G>A genotype alters postprandial plasma levels of free fatty acids in obese individuals with type 2 diabetes mellitus.
    Fontaine-Bisson B; Wolever TM; Chiasson JL; Rabasa-Lhoret R; Maheux P; Josse RG; Leiter LA; Rodger NW; Ryan EA; El-Sohemy A
    Metabolism; 2007 May; 56(5):649-55. PubMed ID: 17445540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Association between tumor necrosis factor-alpha promoter polymorphisms and type 2 diabetes and obesity in Chilean elderly women].
    Santos M JL; Patiño G A; Angel B B; Martínez H JA; Pérez B F; Villarroel B AC; Sierrasesúmaga A L; Albala B C
    Rev Med Chil; 2006 Sep; 134(9):1099-106. PubMed ID: 17167711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of tumor necrosis factor (TNF) promoter polymorphisms with plasma TNF-α levels and susceptibility to diabetic nephropathy in North Indian population.
    Gupta S; Mehndiratta M; Kalra S; Kalra OP; Shukla R; Gambhir JK
    J Diabetes Complications; 2015 Apr; 29(3):338-42. PubMed ID: 25704106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of TNF-α G-308A promoter polymorphism in glycemic control in Type 2 diabetes patients.
    Al-Azzam SI; Khabour OF; Alzoubi KH; Ghanma MW; Alhasan AY
    J Endocrinol Invest; 2014 Feb; 37(2):113-8. PubMed ID: 24497209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study the Association of Tumor Necrosis Factor Promoter Polymorphism with Type 2 Diabetic Nephropathy.
    Emara M; El-Edel R; Fathy WM; Aboelkhair NT; Watany MM; Abou-Elela DH
    Mediators Inflamm; 2020; 2020():1498278. PubMed ID: 32684830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic disposition and modifiable factors independently associated with anemia in patients with type 2 diabetes mellitus.
    Chiou TT; Lee JJ; Wang MC; Chung MS; Pan LL; Hsieh CJ; Huang ST; Chang HW; Yang KD; Lee CT; Liu RT
    Diabetes Res Clin Pract; 2015 Apr; 108(1):164-9. PubMed ID: 25656761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The -238 and -308 G-->A polymorphisms of the tumor necrosis factor alpha gene promoter are not associated with features of the insulin resistance syndrome or altered birth weight in Danish Caucasians.
    Rasmussen SK; Urhammer SA; Jensen JN; Hansen T; Borch-Johnsen K; Pedersen O
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1731-4. PubMed ID: 10770222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of the tumor necrosis factor-alpha -308 A/G promoter polymorphism with insulin sensitivity and abdominal fat distribution in Japanese patients with type 2 diabetes mellitus.
    Furuta M; Yano Y; Ito K; Gabazza EC; Katsuki A; Tanaka T; Ohtake K; Hirata N; Hori Y; Araki-Sasaki R; Sumida Y; Adachi Y
    Diabetes Res Clin Pract; 2002 May; 56(2):141-5. PubMed ID: 11891022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A polymorphism in the promoter of the tumor necrosis factor-alpha gene (-308) is associated with coronary heart disease in type 2 diabetic patients.
    Vendrell J; Fernandez-Real JM; Gutierrez C; Zamora A; Simon I; Bardaji A; Ricart W; Richart C
    Atherosclerosis; 2003 Apr; 167(2):257-64. PubMed ID: 12818408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine promoter polymorphisms in Taiwanese patients with Graves' disease.
    Shiau MY; Huang CN; Yang TP; Hwang YC; Tsai KJ; Chi CJ; Chang YH
    Clin Biochem; 2007 Feb; 40(3-4):213-7. PubMed ID: 17208210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different susceptibility to insulin resistance and fatty liver depending on the combination of TNF-α C-857T and adiponectin G+276T gene polymorphisms in Japanese subjects with type 2 diabetes.
    Ohara M; Maesawa C; Takebe N; Takahashi T; Yamashina M; Ono M; Matsui M; Sasai T; Honma H; Nagasawa K; Fujiwara F; Kajiwara T; Taneichi H; Takahashi K; Satoh J
    Tohoku J Exp Med; 2012 Feb; 226(2):161-9. PubMed ID: 22327199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.